Latest / UF Health MedEd Cast / University of Florida Neuro Research Ranks No. 2 Nationally in NIH Funding
Transcript
- 0:03Melanie Cole (Host): Welcome to UF Health Med EdCast with UF Health Hans Hospital.
- 0:07I'm Melanie Cole, and today we're highlighting how according to the 2025
- 0:11Blue Ridge rankings for NIH funding, the UF departments of neurosurgery and
- 0:17neurology, neuroscience research ranks number two nationally in NIH funding.
- 0:24Joining me in this panel is Dr.
- 0:25Brian Ho.
- 0:26He's the James and Jit Marino family professor and chair of the Lillian
- 0:31s Wells Department of Neurosurgery at the University of Florida.
- 0:34And Dr.
- 0:35Ho is also the chief of the medical staff at UF Health Shan Hospital.
- 0:39And Dr.
- 0:40Michael Jaffe.
- 0:41He's the chair in the Department of Neurology, director of Brain Injury
- 0:45Rehabilitation and Neuro Resilience Center, and a Bob Paul family,
- 0:49professor of neurology doctors.
- 0:51Thank you so much for joining us today and Dr.
- 0:54Ho.
- 0:54To start, I'd like you to give us the big.
- 0:56Picture, what does it mean for the University of Florida neuro research to
- 1:00rank number two nationally in NIH funding?
- 1:03From your perspective as clinician scientist, why is this
- 1:08milestone more than just a number?
- 1:11Dr Brian Hoh: Yeah.
- 1:11Thanks Melanie, and thank you for that question.
- 1:14I think that, the real importance of This is that our faculty, our trainees
- 1:22and our students And the Department of Neurosurgery at the University of
- 1:26Florida are conducting science and doing research That is impactful.
- 1:32And we'll translate into real novel changes and therapies
- 1:37that will improve the lives of, patient's now And in the future.
- 1:41and This is one way of measuring the impact of that.
- 1:45but, we really, have this vision And this mission to do more, for our patient's and
- 1:50to improve their health and their lives.
- 1:53Melanie Cole (Host): Well, I think that's so important.
- 1:54And so then along those lines, Dr.
- 1:56Jaffe, as we think about the role of NIH funding, why it's such a
- 2:00critical driver of innovation in neurology and neurosurgery, how does
- 2:05strong NIH support translate into attracting top tier talent, fostering
- 2:10collaboration, and advancing research?
- 2:13Dr Michael Jaffe: so.
- 2:14having the opportunity to have competitive grants for NIH does make
- 2:18for an attractive research environment.
- 2:21you hit on something that I believe is a, key element and an ingredient
- 2:26for the success that we've had, And that being collaboration And that our
- 2:30investigators collaborate with many different departments and even across
- 2:35colleges here at the University of Florida, oftentimes producing these
- 2:39innovative, interdisciplinary proposals.
- 2:41That I think catch the eye of NIH 'cause they realize the synergy that a place like
- 2:46the University of Florida can provide.
- 2:48And so, when you have that kind of an environment with the natural
- 2:52collaborations and support, it really makes itself conducive to team science and
- 2:58a way to be attractive to, the scientists.
- 3:02But even more important than being attracted to the
- 3:04scientists, I think that, Dr.
- 3:07Ho might agree that.
- 3:08Having this kind of environment really makes us an exciting place for patient's
- 3:13because what it does is it shows that we're on the cutting-edge, And we
- 3:17can oftentimes provide hope as we are pushing the forefront of treatments
- 3:21and knowledge about these diseases.
- 3:24Melanie Cole (Host): Dr.
- 3:24Ho, let's shift into the work coming out of the UF department of neurosurgery.
- 3:29What are some of the most exciting or impactful research areas right
- 3:33now that you're all looking into?
- 3:35Discuss a little bit about the research being conducted at your department.
- 3:39Dr Brian Hoh: Thanks, Melanie.
- 3:40a few areas, where we have exceptionally strong interdisciplinary research
- 3:46where we're making impacts on patient's, include, research into
- 3:51novel therapies, for brain cancer.
- 3:54Our group in the University of Florida Department of Neurosurgery has
- 3:59been developing novel immunotherapy approaches to treat malignant
- 4:04brain cancer, a disease that has a very serious and dismal prognosis.
- 4:11And with this research, they're offering hope.
- 4:14For these patient's using the power And the strength of, each
- 4:18individual patient's immune system and harnessing that power, to fight
- 4:24against, these, horrible brain cancers.
- 4:27Another area, where our department is conducting significant
- 4:30researches in the area of stroke.
- 4:33as you and many people know, stroke.
- 4:36Is a significant leading cause of death And the number one cause of
- 4:40disability in the United States.
- 4:42And so, a group that I'm a, part of a team for is conducting research
- 4:48into, preventing stroke, from intracranial atherosclerotic disease
- 4:53or narrowing of the blood vessels of the brain caused by atherosclerosis.
- 4:58This is a, condition that has a very high.
- 5:02Rate of stroke and death, in patient's.
- 5:05And so, we have been conducting a, major national, stroke
- 5:09trial, studying three different treatments, to prevent, stroke from,
- 5:14intracranial atherosclerotic disease.
- 5:17Melanie Cole (Host): That's so exciting, the work that you're doing.
- 5:20It's a really exciting time in your field.
- 5:22And along those lines then, Dr.
- 5:24Ho, when you're taking us from bench to bedside, how is innovation?
- 5:30AI surgical techniques changing that neurosurgical landscape at uf 'cause
- 5:35that's such an exciting prospect.
- 5:39Dr Brian Hoh: Yes, definitely.
- 5:40and That is one of the reasons why I chose Neurosurgery,
- 5:44neuroscience as a field is because.
- 5:47Among all the medical disciplines, Neurosurgery, neurology, neuroscience
- 5:53is one of the most rapidly changing, innovative, fields in medicine.
- 5:58And, novel, imaging novel diagnostic methods and novel therapies continue,
- 6:05to come in a fast and rapid pace.
- 6:08And so, in the UF department of Neurosurgery We've made it our, vision
- 6:13and our mission to contribute that and contribute to that in a significant way.
- 6:17some of the, immunotherapy, treatments that have been developed
- 6:21by our faculty in the laboratory in preclinical experiments are now.
- 6:28Actually being delivered to human patient's with malignant brain cancer.
- 6:32First in human clinical trials, really an example of bench to bedside, treatment.
- 6:40There are many other areas that the UF Department of Neurosurgery
- 6:43is translating research to bedside treatments for patient's,
- 6:47including in the realm of movement disorders with novel, innovative...
- 6:53Devices and brain stimulation techniques, focused ultrasound, the treatment of
- 6:59vascular diseases with novel endovascular devices and procedures, and then the
- 7:06treatment of brain tumors with laser interstitial thermal therapy, as well as
- 7:12a clinical trial using focused ultrasound.
- 7:15So, it's a very exciting time.
- 7:17and I'm excited to be a part of this field where there's
- 7:20rapid, innovation, and change.
- 7:23Melanie Cole (Host): Well, thank you for sharing that with us and Dr.
- 7:26Jaffe turning to neurology.
- 7:28Tell us about some of the major research priorities you have right now across
- 7:31the UF Department of Neurology and really how neurologists at UF are
- 7:36bridging that bench research with real-world clinical application.
- 7:41Dr Michael Jaffe: So one of the things I'm most proud of about the
- 7:43research portfolio in the Department of Neurology is its utter variety.
- 7:48It's depth and breadth And that we have initiatives that are focused
- 7:53on common conditions to even some of the most rare conditions.
- 7:59And so as an example, we have, an exciting protocol that's using non-invasive,
- 8:05stimulation to help enhance walking and cognition in older people as we age.
- 8:10Looking at the linkages between.
- 8:12The decreased, walking ability is along with cognition is a common
- 8:16challenge of aging, all the way to some of the most rare conditions.
- 8:20We actually have a, initiative looking at using technology to stimulate the
- 8:25brain, to treat, spinal cerebellar ataxia, which is a genetic form of,
- 8:31uh, progressive ability to, lose balance And the ability to walk,
- 8:35which is a, a rare genetic condition.
- 8:38And when you also look at this, we go across the entire spectrum of settings
- 8:43of what we have from acute into an ICU setting to a chronic outpatient setting.
- 8:49And so, for example, in the acute ICU setting, we have a protocol
- 8:53using innovative nerve blocks to help with pain control and people that
- 8:58have had a subarachnoid hemorrhage.
- 9:00And then looking at even more of the outpatient kinds of clinics,
- 9:04we have a variety of initiatives.
- 9:07or people say with Parkinson's disease or being treated on the
- 9:10outpatient basis, that helps open up the door to understanding
- 9:15both pathologies and treatments.
- 9:17We have a newer initiative that's kind of using functional MRI to map out
- 9:22the neuronal networks that might be contributing to anxiety that people with
- 9:27Parkinson's may have and how that may look differently, when they're on a medicine
- 9:32versus when they're off of a medicine.
- 9:34we have everything from testing and developing high tech innovative devices
- 9:41to, even a grant where we were developing policy for the state of Florida to help
- 9:47those with acquired brain injuries.
- 9:49And so, when I look at the entire portfolio, I just like to think
- 9:54of it as being deep and wide.
- 9:56Melanie Cole (Host): That is so interesting.
- 9:57So then, Dr.
- 9:59Ho, I'd like you to speak a little bit about the interdisciplinary collaboration,
- 10:04and especially between neurology and neurosurgery as you two work so well
- 10:09together in advancing these efforts as far as the importance of these types
- 10:13of research that both departments are doing And the impact on the health
- 10:18of patient's, as you have seen.
- 10:21Dr Brian Hoh: So, in every example that, Dr.
- 10:24Jaffe and I spoke about in terms of, research initiatives and programs out
- 10:29of our true departments, these are all active, interdisciplinary collaborations.
- 10:36Between neurology, Neurosurgery, neuroscience, and many other, departments.
- 10:41So just to name a few examples, Dr.
- 10:44Jaffe alluded to a clinical trial investigating ways to, prevent and reduce
- 10:50headache after subarachnoid hemorrhage.
- 10:53That is a multi I clinical trial called block, SAH, And the
- 10:58principal investigators, come from the Department of neurology.
- 11:03Department of Neurosurgery And the Department of Anesthesiology.
- 11:07And so, That is just one example, multi pi, multidisciplinary, multi-departmental,
- 11:15collaboration in a, large, national multicenter, randomized clinical trial.
- 11:21another example.
- 11:23is in, research, in, movement disorders, which has been a, longstanding,
- 11:28fruitful and productive collaboration between, the departments of neurology
- 11:33And the departments of Neurosurgery and, the departments of biomedical
- 11:37engineering, understanding and mapping, brain pathways, neuroanatomy.
- 11:44Brain connections And then developing, novel brain stimulation techniques,
- 11:49to treat, neurodegenerative disorders.
- 11:53And then finally, treatments for, malignant brain cancer bridge.
- 11:57Many departments including neurosurgery, neurology.
- 12:01Radiology.
- 12:02Melanie, you mentioned AI, AI is a very active and integral part, of the brain.
- 12:08cancer, research, as well as immunotherapy, immunology,
- 12:14And the basic neurosciences.
- 12:15So, none of this research could be done without active, and collaborative,
- 12:21relationships between multiple departments And in, many cases, multiple colleges.
- 12:27Melanie Cole (Host): Yes, Those are such important points and I'd love to give
- 12:30you each a chance for final thought here.
- 12:32So, Dr.
- 12:33Jaffe, what does it mean for patient's to be treated at a center with this
- 12:37depth of NIH supported research?
- 12:40And looking ahead, what areas of neuroscience research are
- 12:44you most excited about over the next five or 10 years or so?
- 12:48Dr Michael Jaffe: it is an exciting time and sort of the
- 12:51build on this whole idea of.
- 12:53One of the things that we provide is this interactive collaboration, what some
- 12:58people would refer to as team science.
- 13:01And so we have the opportunity to bring together these teams who then together
- 13:06can push the technology that can open up more understanding, open up the
- 13:11next generation of questions, and we've seen that we have some investigators
- 13:15who've been working together for years, And then they're bringing in
- 13:18the experts from the newer technology.
- 13:20So.
- 13:21To kind of build upon an example that Dr.
- 13:23Ho gave is that whenever we talk about, some of the research that
- 13:28involves deep brain stimulation, it definitely is a collaboration between
- 13:32all the disciplines that he said, neurosurgery, neurology, and engineering.
- 13:36And what we have seen over time now is even with that, they are now using AI
- 13:41to sort of talk about, how to improve the programming of the stimulator
- 13:46to give even more precision, care.
- 13:48To the individuals.
- 13:49And so we are looking at newer generations of technology to
- 13:54improve the treatments that we have.
- 13:57And we're also looking at newer generations of technology to
- 14:01better understand what we have.
- 14:02And so one of the newest pieces of equipment that we've had for
- 14:06the past couple of years, it is called a magneto celo That is
- 14:10used for advanced brain mapping.
- 14:13And having that opportunity for advanced brain mapping helps us.
- 14:17One, understand the pathophysiology of disease, but two directly translate
- 14:23into helping people because as Dr.
- 14:25Ho was talking about the importance of brain cancer, for example, that kind
- 14:30of brain mapping technology from the magneto encephalopathy can be used to help
- 14:34plan, brain cancer forms of surgeries.
- 14:37And we are using it to, better.
- 14:40Plan and collaborate with neurosurgery for epilepsy surgeries to having a
- 14:44very precise surgical intervention to improve the lives of people.
- 14:49And so overall, what we're heading for is the precision that we can gain
- 14:55through understanding the disease, through personalizing the medicine,
- 14:59understanding the genetics or the things that are unique to that individual.
- 15:03So that we can tailor that treatment with this higher technology to be
- 15:07specific to what that individual needs.
- 15:10With the idea that being no two individuals might
- 15:13get exactly the same thing.
- 15:15That the treatments themselves are using this technology to really
- 15:19hone in on the exact precision intervention needed for that individual.
- 15:24And so That is kind of what we are continuing to evolve towards
- 15:28as we continue to do our best to.
- 15:30Improve the qualities of, life for people with neurological diseases,
- 15:35through a variety of interventions, which would include technology, which
- 15:39would include surgery, which would include medications, which would include
- 15:43a variety of other therapies, which might include non-invasive stimulation.
- 15:48As so as we are trying to push the envelope on all of these, both
- 15:52treatments and technologies and diagnostics to allow us to better help
- 15:56people and improve quality of life.
- 15:58Melanie Cole (Host): What a fascinating discussion and field that you're both in.
- 16:03Thank you so much, Dr.
- 16:04Jaffe.
- 16:04And Dr.
- 16:05Ho, last word to you.
- 16:06How will sustained NIH funding continue to shape the future of
- 16:10neurologic and neurosurgical care?
- 16:12And what would you like clinicians listening to take away about the
- 16:17importance of engaging with research regardless of their practice setting?
- 16:22Dr Brian Hoh: I think the takeaway message, Melanie, is that, Support,
- 16:26from the federal government through NIH funding and other federal agencies
- 16:32is so critical And so important to sustaining, the vital research that we
- 16:39and many other, academic medical centers across the country are performing.
- 16:45but what I'd like to, express to clinicians and.
- 16:48To other's listening is that, the research that, we are conducting, here at the
- 16:53University of Florida And the Department of Neurosurgery as well as neurology
- 16:57is research That is having, uh, direct translational impact on patient's.
- 17:04And we're not talking about something way off in the future,
- 17:07but actually, today, direct.
- 17:10Translation from, novel therapies that our faculty have developed in the laboratory
- 17:16that are being used now to treat patient's, today and having a real impact.
- 17:21And so, the sustained Manintim that we're hoping to continue, with our, scientific
- 17:27discovery, is to really work on.
- 17:30Finding ways that we can make direct impacts on improving
- 17:33the lives and the health of patient's, today and in the future.
- 17:38Melanie Cole (Host): Very well said.
- 17:39Thank you both so much for joining us today and sharing your incredible
- 17:44expertise as clinicians, scientists, and practicing physicians.
- 17:49Thank you so much.
- 17:50And to learn more about this and other healthcare topics at UF
- 17:54Health Chance Hospital, please visit innovation dot uf health.org
- 17:58and to listen to more podcasts from our experts, you can
- 18:01always go to UF health.org/med
- 18:04matters.
- 18:05That concludes today's episode of UF Health Med EdCast with
- 18:09UF Health Hans Hospital.
- 18:10I'm Melanie Cole.